| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.658 | 26.577 | 29.827 | 40.978 | 62.919 | 69.362 | 69.717 | 76.781 | 99.990 | 121.340 |
| Total Income - EUR | 23.658 | 26.577 | 29.827 | 40.978 | 62.919 | 71.429 | 69.717 | 76.781 | 99.990 | 121.357 |
| Total Expenses - EUR | 16.315 | 21.129 | 27.365 | 44.547 | 43.607 | 51.743 | 65.157 | 70.347 | 74.719 | 61.678 |
| Gross Profit/Loss - EUR | 7.343 | 5.448 | 2.462 | -3.569 | 19.313 | 19.686 | 4.560 | 6.434 | 25.271 | 59.679 |
| Net Profit/Loss - EUR | 6.633 | 5.059 | 1.878 | -3.979 | 18.683 | 19.075 | 4.069 | 5.782 | 24.411 | 56.584 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 |
Check the financial reports for the company - Giada-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.040 | 1.758 | 1.473 | 1.194 | 1.568 | 1.097 | 772 | 210 | 0 | 83 |
| Current Assets | 5.372 | 4.533 | 4.892 | 4.204 | 14.675 | 38.863 | 33.862 | 35.224 | 62.180 | 116.897 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 344 |
| Receivables | 362 | 995 | 2.047 | 3.823 | 1.124 | 1.264 | 2.669 | 1.299 | 9.382 | 3.554 |
| Cash | 5.009 | 3.539 | 2.845 | 381 | 13.550 | 37.598 | 31.193 | 33.925 | 52.798 | 112.999 |
| Shareholders Funds | -19.149 | -13.895 | -11.781 | -15.545 | 3.440 | 22.450 | 26.021 | 31.883 | 56.198 | 112.468 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.561 | 20.187 | 18.146 | 20.943 | 12.802 | 17.510 | 8.614 | 3.551 | 5.982 | 4.513 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Giada-Med Srl